SDPO

Serial Number 79295436
Registration 6268985
404

Registration Progress

Application Filed
Aug 6, 2020
Under Examination
Approved for Publication
Nov 11, 2020
Published for Opposition
Dec 1, 2020
Registered
Feb 16, 2021

Trademark Image

SDPO

Basic Information

Serial Number
79295436
Registration Number
6268985
Filing Date
August 6, 2020
Registration Date
February 16, 2021
Published for Opposition
December 1, 2020
Cancellation Date
September 14, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
404
Status Date
Dec 15, 2023

Rights Holder

Sumitomo Dainippon Pharma Co., Ltd.

03
Address
6-8, Doshomachi 2-chome,
Chuo-ku, Osaka-shi Osaka 541-0045
JP

Ownership History

Sumitomo Dainippon Pharma Co., Ltd.

Original Applicant
03
JP

Sumitomo Dainippon Pharma Co., Ltd.

Owner at Publication
03
JP

Sumitomo Dainippon Pharma Co., Ltd.

Original Registrant
03
JP

USPTO Deadlines

Next Deadline
550 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-02-16)
Due Date
February 16, 2027
Grace Period Ends
August 16, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description Documents
Oct 2, 2023 DENC O NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Loading...
Oct 1, 2023 DETH P DEATH OF INTERNATIONAL REGISTRATION Loading...
Apr 11, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Mar 20, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 20, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Mar 18, 2021 GPAR P GRANT OF PROTECTION CREATED, TO BE SENT TO IB Loading...
Feb 16, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 1, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 11, 2020 NPUB O NOTICE OF PUBLICATION Loading...
Oct 26, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 20, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 20, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 15, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Oct 8, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Additional Information

Pseudo Mark
SUMITOMO DAINIPPON PHARMA ONCOLOGY